Han H, Zhang C, Shi W, Wang J, Zhao W, Du Y
Adv Sci (Weinh). 2024; 12(2):e2404083.
PMID: 39531371
PMC: 11727281.
DOI: 10.1002/advs.202404083.
Ma M, Yi L, Pei Y, Zhang Q, Tong C, Zhao M
Nat Commun. 2024; 15(1):7856.
PMID: 39251623
PMC: 11385750.
DOI: 10.1038/s41467-024-52201-z.
Wu Z, Xie L, Yuan P, Chu Y, Peng H
Neoplasia. 2024; 56:101033.
PMID: 39067242
PMC: 11372390.
DOI: 10.1016/j.neo.2024.101033.
Ling X, Xu W, Tang J, Cao Q, Luo G, Chen X
Invest Ophthalmol Vis Sci. 2024; 65(6):29.
PMID: 38888282
PMC: 11186577.
DOI: 10.1167/iovs.65.6.29.
Jiang H, Qin H, Yang Q, Huang L, Liang X, Wang C
J Nanobiotechnology. 2024; 22(1):292.
PMID: 38802882
PMC: 11129471.
DOI: 10.1186/s12951-024-02561-x.
RNA-binding protein PTENα blocks RIG-I activation to prevent viral inflammation.
Yin Y, Yang Z, Sun Y, Yang Y, Zhang X, Zhao X
Nat Chem Biol. 2024; 20(10):1317-1328.
PMID: 38773328
DOI: 10.1038/s41589-024-01621-5.
The NTE domain of PTENα/β promotes cancer progression by interacting with WDR5 via its SSSRRSS motif.
Huang X, Zhang C, Shang X, Chen Y, Xiao Q, Wei Z
Cell Death Dis. 2024; 15(5):335.
PMID: 38744853
PMC: 11094138.
DOI: 10.1038/s41419-024-06714-6.
Unraveling the Concealed Transcriptomic Landscape of PTEN in Human Malignancies.
Boti M, Adamopoulos P, Vassilacopoulou D, Scorilas A
Curr Genomics. 2024; 24(4):250-262.
PMID: 38169628
PMC: 10758127.
DOI: 10.2174/0113892029265367231013113304.
PTEN-mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells.
He J, Huang C, Guo Y, Deng R, Li L, Chen R
Mol Oncol. 2023; 18(3):580-605.
PMID: 38060346
PMC: 10920079.
DOI: 10.1002/1878-0261.13563.
MG modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma.
He M, Wang Y, Xie J, Pu J, Shen Z, Wang A
Oncogene. 2023; 43(5):341-353.
PMID: 38040806
DOI: 10.1038/s41388-023-02882-5.
Roles of USP9X in cellular functions and tumorigenesis (Review).
Meng Y, Hong C, Yang S, Qin Z, Yang L, Huang Y
Oncol Lett. 2023; 26(6):506.
PMID: 37920433
PMC: 10618932.
DOI: 10.3892/ol.2023.14093.
A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance.
Hao J, Huang J, Hua C, Zuo Y, Yu W, Wu X
PLoS Biol. 2023; 21(9):e3002256.
PMID: 37708089
PMC: 10501593.
DOI: 10.1371/journal.pbio.3002256.
Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma.
Cui J, He Y, Zhu F, Gong W, Zuo R, Wang Y
Int J Biol Sci. 2023; 19(13):4061-4081.
PMID: 37705753
PMC: 10496496.
DOI: 10.7150/ijbs.82980.
Novel anti-PTEN C2 domain monoclonal antibodies to analyse the expression and function of PTEN isoform variants.
Torices L, Nunes-Xavier C, Lopez J, Pulido R
PLoS One. 2023; 18(8):e0289369.
PMID: 37527256
PMC: 10393154.
DOI: 10.1371/journal.pone.0289369.
Hyperphosphorylated PTEN exerts oncogenic properties.
van Ree J, Jeganathan K, Fierro Velasco R, Zhang C, Can I, Hamada M
Nat Commun. 2023; 14(1):2983.
PMID: 37225693
PMC: 10209192.
DOI: 10.1038/s41467-023-38740-x.
ANP32B suppresses B-cell acute lymphoblastic leukemia through activation of PU.1 in mice.
Yang Q, Liu H, Yang S, Wei Y, Zhu X, Zhi Z
Cancer Sci. 2023; 114(7):2882-2894.
PMID: 37137487
PMC: 10323103.
DOI: 10.1111/cas.15822.
Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.
Langdon C
Biomolecules. 2023; 13(2).
PMID: 36830628
PMC: 9953540.
DOI: 10.3390/biom13020259.
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
Zhu X, Wei Y, Yang Q, Liu H, Zhi Z, Zhu D
J Hematol Oncol. 2023; 16(1):9.
PMID: 36774506
PMC: 9922468.
DOI: 10.1186/s13045-023-01400-0.
ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
Yang W, Wang B, Yu Q, Liu T, Li T, Tian T
Theranostics. 2022; 12(14):6189-6206.
PMID: 36168627
PMC: 9475462.
DOI: 10.7150/thno.72134.
PTEN Dual Lipid- and Protein-Phosphatase Function in Tumor Progression.
Liu A, Zhu Y, Chen W, Merlino G, Yu Y
Cancers (Basel). 2022; 14(15).
PMID: 35954330
PMC: 9367293.
DOI: 10.3390/cancers14153666.